Red LED photobiomodulation reduces pain hypersensitivity and improves sensorimotor function following mild T10 hemicontusion spinal cord injury by Hu, Di et al.
RESEARCH Open Access
Red LED photobiomodulation reduces pain
hypersensitivity and improves sensorimotor
function following mild T10 hemicontusion
spinal cord injury
Di Hu1, Shuyu Zhu1 and Jason Robert Potas1,2*
Abstract
Background: The development of hypersensitivity following spinal cord injury can result in incurable persistent
neuropathic pain. Our objective was to examine the effect of red light therapy on the development of
hypersensitivity and sensorimotor function, as well as on microglia/macrophage subpopulations following spinal
cord injury.
Methods: Wistar rats were treated (or sham treated) daily for 30 min with an LED red (670 nm) light source
(35 mW/cm2), transcutaneously applied to the dorsal surface, following a mild T10 hemicontusion injury (or sham
injury). The development of hypersensitivity was assessed and sensorimotor function established using locomotor
recovery and electrophysiology of dorsal column pathways. Immunohistochemistry and TUNEL were performed to
examine cellular changes in the spinal cord.
Results: We demonstrate that red light penetrates through the entire rat spinal cord and significantly reduces signs
of hypersensitivity following a mild T10 hemicontusion spinal cord injury. This is accompanied with improved dorsal
column pathway functional integrity and locomotor recovery. The functional improvements were preceded by a
significant reduction of dying (TUNEL+) cells and activated microglia/macrophages (ED1+) in the spinal cord. The
remaining activated microglia/macrophages were predominantly of the anti-inflammatory/wound-healing
subpopulation (Arginase1+ED1+) which were expressed early, and up to sevenfold greater than that found in
sham-treated animals.
Conclusions: These findings demonstrate that a simple yet inexpensive treatment regime of red light reduces the
development of hypersensitivity along with sensorimotor improvements following spinal cord injury and may
therefore offer new hope for a currently treatment-resistant pain condition.
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Background
The experience of pain serves as an essential survival
mechanism that motivates us to protect ourselves from
harm; however, following spinal cord injury, the develop-
ment of treatment-resistant neuropathic pain often en-
sues, bringing no advantage to the sufferer but severely
reducing the quality of life. Chronic pain affects a vast
sector of the population for which the socioeconomic
cost exceeds that of heart disease, cancer and diabetes
[1]; thus, successfully treating neuropathic pain would
bring significant benefits.
The non-invasive application of light, at wavelengths
that penetrate transcutaneously [2], has begun to emerge
as a potential therapy for improving functional outcomes
from a variety of neural injuries [3]. Photobiomodulation
with wavelengths ranging from 630 to 1100 nm has
demonstrated positive effects in animal models of neuro-
degenerative diseases such as Alzheimer’s [4] and
Parkinson’s [5], genetic models of dementia [6], as well
as acute nervous injuries to the retina [7–9], optic nerve
[9, 10], sciatic nerve [11–15] and spinal cord [16]. In
humans, photobiomodulation has been reported to be
effective against a variety of pain conditions including
mucositis [17], carpel tunnel syndrome [18–20], ortho-
dontic pain [21], temporomandibular joint pain [22],
neck pain [23] and neuropathic pain resulting from am-
putation [24].
Inflammatory mediators have long been implicated in
the development and maintenance of pain [25–28].
These chemical mediators are controlled by a variety of
immune cells including the balance of pro- and anti-in-
flammatory microglia/macrophage subpopulations
[29–35]. As in non-neural tissues, macrophages can be
activated by T helper cell type 1 (Th1) or type 2 (Th2)
to generate opposing immune responses following spinal
cord injury [30, 31]. Th1-activated microglia/macro-
phages (M1) have been considered potentially damaging
to healthy tissues, as they induce a pro-inflammatory
response and have been shown to inhibit axonal regener-
ation [30]. Conversely, Th2-activated microglia/macro-
phages (M2) have been considered protective, as they
have a role in suppressing the pro-inflammatory response
by producing anti-inflammatory mediators [30, 31]. Fol-
lowing spinal cord injury, there is evidence suggesting that
the M1 response prevails over a more transient M2 re-
sponse, and this observation has been proposed to con-
tribute to the poor regenerative capacity of the spinal cord
following injury [30, 31]. Consistent among various in
vitro and in vivo studies, including spinal cord and periph-
eral nerve injury models, are reports of reduced levels of
pro-inflammatory cell mediators, including as IL-6, iNOS,
MCP-1, IL-1β and TNFα in response to treatment with
various wavelengths including 633 nm [36], 660 nm,
780 nm [37], 810 nm [16] and 950 nm [14]. Coincidently,
these pro-inflammatory cell mediators are secreted by M1
cells; thus, we were curious to examine the effect of light
treatment on microglia/macrophage populations.
There are various wavelengths used throughout the lit-
erature which demonstrate biological effects. In an at-
tempt to find the better wavelength option for treating
nervous system injuries, one study compared the effects
of two wavelengths in a variety of CNS injury models, to
find that 670 nm treatment resulted in better outcomes
for a number of parameters when compared to 830 nm
[9]. Our aim therefore was to evaluate the effect of the
670 nm wavelength following spinal cord injury on a
variety of functional parameters, namely the develop-
ment of hypersensitivity to innocuous stimuli (allodynia),
as well as on (tactile) sensory pathway conduction and
locomotor recovery, and to see if there were alterations
to the M1/M2 sub-populations. We found that red light
treatment significantly reduced the severity of hypersen-
sitivity while improving sensorimotor function and that
these improvements were preceded by an anti-
inflammatory microglia/macrophage cell population in
the injury zone.
Methods
Hemicontusion spinal cord injury
All animal work was approved by the ANU Animal
Experimentation Ethics Committee. Hemicontusion
spinal cord injuries were performed on 7-week-old
Wistar rats under isoflurane (1.7–2.3 % v/v) anaesthesia.
Following hair removal, a laminectomy of T10 vertebral
body and removal of dura and arachnoid was performed,
followed by a spinal cord hemicontusion using a cus-
tomized impactor system [38] comprising of a cylindrical
10 g weight with a 1-mm diameter tip that was guided
onto the right dorsal horn and dropped from 25 to
50 mm above the spinal cord.
Treatment and experimental groups
Injured animals were divided into 670-nm-treated
(SCI+670) and sham-treated (SCI) groups. SCI+670
rats received 30 min of 670 nm irradiation commen-
cing 2 h after surgery and then every 24 h after
locomotor assessment for the remainder of the recov-
ery period. A commercially available 670 nm LED
array (WARP 75A, Quantum Devices, Barneveld, WI;
75 mm2 treatment area) was used for treatment. Spectral
characteristics and power output (Fig. 1) of the LED were
measured using a spectrometer (CCS175, Thorlabs) and
custom made power meter that was calibrated against a
commercially available power meter (PM100D, ThorLabs).
Treatment was delivered through a transparent treatment
box which was used to confine the animal within its home
cage. This resulted in a 7-mm distance between the dorsal
surface of the animal and the LED array and delivery of
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35 mW/cm2 (fluence = 63 J/cm2) of 670 nm at the contact
surface of the animal’s dorsum. SCI rats (n = 29) were re-
strained in the identical way as the SCI+670 group (n = 29),
but without the LED device switched on to control for
30 min restraint in the transparent treatment box. Three
additional control groups were included: an intact unin-
jured group (control; n = 7) was untreated and did not
receive any sham operations or sham treatment; a sham-
injured group (shamSCI; n = 8) underwent the spinal
surgery, but without the contusion, and was subjected to
sham treatment; a sham-injured 670-nm-treated group
(shamSCI+670; n = 10) underwent spinal surgery without
the contusion and received daily 30 min treatments.
Light penetration
Uninjured, unshaven animals (n = 6) were euthanised
with sodium pentobarbital solution (325 mg/ml; Virbac;
dosage, 100 mg/kg). The overlaying heart, great vessels
and muscles were detached from the anchoring connect-
ive tissues and retracted to the side to expose the under-
lying vertebral column. The T10 vertebral body was
eroded with a dental drill to expose the spinal cord from
the ventral surface. The cadaver was placed on its back
in an inverted transparent treatment box so that the dor-
sum of the cadaver could be positioned over the 670 nm
LED array and the ventral surface of the rat was
accessible to enable placement of a custom-built light
measuring device. This device comprised of a photo-
diode chip (surface area, 0.62 mm2; maximal response
(>95 %) to 630–685 nm; ODD-660W, Opto Diode
Corp.) that was fixed to the bottom of an aluminium cy-
linder (height, 7.0 mm; external diameter, 8.7 mm). The
top of the cylinder was sealed with a glass coverslip, and
the entire probe was painted with black paint but leaving
a small circular window (4.0 mm diameter) centred over
the chip sensor. This left a ~2.4-mm lip between the ex-
ternal edge of the glass window and the external circum-
ference of the cylinder. When pressed onto the ventral
surface of the spinal cord, no light could penetrate from
the side because the chip was located 7.0 mm behind
the 4.0-mm aperture; thus, only light rays between 71°
and 90° are able to reach the surface of the sensor; an-
gles deviating from 90° do not hit the entire surface of
the photosensitive diode and therefore contribute less to
the total power reading. The signal from the probe was
amplified by a custom amplifier built for purpose. The
key component was the logarithmic converter amplifier
(AD8304, Analog Devices). The readings were then
calibrated against a commercially available light power
meter tuned at 670 nm (PM100D ThorLabs) by produ-
cing a calibration table for different radiant power
(controlled by distance from the light source) and
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Fig. 1 Externally applied red light penetrates through the entire rat spinal cord. a Photograph shows the ventral surface of the spinal cord
following removal of the T10 vertebral body in a cadaver rat. Topography of the vertebral column is shown centred around the 10th vertebral
body under normal light conditions. b The identical region as shown in a, with a 670 nm LED array light source (35 mW/cm2) placed directly on
the dorsum of the animal and with ambient lights switched off. Note the visible red light illuminating from the ventral surface of the cord
(exposed, arrow) indicating excess penetration through dorsal layers of the hair, skin, muscle, bone and spinal cord. c Intensities measured by a
670 nm power meter are shown for six freshly sacrificed cadaver rats (each dot represents the mean of triplicate readings). Readings shown are
taken at the light source (through the Perspex restraining box, intensity at dorsal surface) and at the ventral surface of the spinal cord as shown
by the white arrow in b (intensity at ventral surface). Black arrow indicates proportion of light absorbed and/or scattered by intervening tissues.
d Spectral analysis of the light source indicating central frequency of 675 nm
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subsequently converted into intensity (power/unit area).
The probe was used to determine light intensity from the
670 nm array through (i) the treatment box, (ii) the spinal
cord and dorsal overlying structures and (iii) the equiva-
lent space through the air to provide a measure of attenu-
ation over the distance of the light path. Prior to
activating the LED, ambient lights were switched off; how-
ever, we also confirmed that no photons were detected by
the light meter with the ambient lights on. Three repeat
readings were acquired for each measurement.
Example images were obtained with a D1X Nikon
(5.3 megapixels) camera and 120-mm lens (Medical
NIKKOR) with a ×2 adaptor and built in ring flash.
Images were captured with both the ambient lights
and LED array on and then repeated in the same pos-
ition with the ambient lights off.
Temperature measurement
A temperature probe (ML309/MLT422, ADInstruments)
connected to a data acquisition system (PowerLab 26T,
LabChart v7.3.7, ADInstruments) was attached to the
dorsum of the animals prior to, and 2 min after sham or
light treatment on consecutive days from four sham-
and four light-treated rats.
Sensitivity assessment
Sensitivity assessment was carried out on day 7 post-
injury prior to locomotor and electrophysiological
assessments. To assess hypersensitivity, a nylon filament
(OD: 1.22 mm) was used to deliver innocuous tactile
stimuli over six defined regions over the animals’ dor-
sum: Above-Level (dermatomes C6-T3), At-Level (der-
matomes T9-T12) and Below-Level (dermatomes L2-L5)
on ipsi- and contralateral sides relative to the injury. The
boundary for each of the six regions was marked on the
animals’ back, and 10 consecutive innocuous “pokes”
were delivered in each boundary at an inter-poke-
interval of approximately 1–2 s, or until the animal re-
covered from movement evoked from the previous poke
if longer than 2 s. Prior to testing, the operator practiced
the stimulus procedure. This ensured that each poke
was as brief as possible, that the filament landed normal
(90°) to the skin surface and that the final position of the
filament handle was approximately half the distance to
that of the distance at initial contact of the filament. This
protocol ensured pokes of consistent duration and max-
imum force which was confirmed using a weighing balance
(maximum bending force: 2.86 ± 0.09 g; n = 10 pokes). Dur-
ing sensitivity testing, animals were “semi-restrained” in a
V-shaped plastic box. This restricted the animal’s ability to
avoid the testing procedure and thereby facilitated the
operator’s accuracy of each poke but enabled sufficient
movement for the animal to display behavioural responses
of interest. Testing was recorded using a webcam (Logitec
HD Pro C920). Videos were assessed blind to the observer
in slow motion play back by evaluating the response to
each innocuous poke that was graded into one of four cat-
egories as (I) no response; (II) mild response characterised
by acknowledgment of the stimulus, head turns, brief shud-
dering of the contacted skin, but no obvious pain avoidance
behaviours; (III) medium response, characterised by moder-
ate signs of pain perception, including moderate avoidance
attempts by moving away from the stimulus and (IV) severe
response, characterised by severe signs of pain perception,
including attacking the stimulus and “desperate” avoidance
attempts and escape behaviours including jumping, run-
ning, writhing or audible vocalization. The four categories,
I–IV, were chosen because these behaviours are easily dis-
tinguishable. The frequency of each response category was
multiplied by a weight; categories I–IV were multiplied by
0, 1, √2 and 2, respectively, to provide greater separation
between ordinal pain behaviours between non-painful and
painful [39], as well as to help minimise heteroscedasticity
of the data. The sum of the 10 weighted responses provided
a regional sensitivity score (RSS) for each region. This para-
digm enables high-resolution measures of sensitivity to 10
innocuous pokes with each possible RSS ranging between 0
and 20. Scores from ipsi- and contralateral regions were
pooled to determine level sensitivity scores (LSS) above, at
and below the level of injury. An cumulative sensitivity
score (CSS) was derived for each animal by summing the
RSS from all six regions; the maximum CSS possible is
therefore 120. The hypersensitivity threshold was defined
by the mean + 2 standard deviations (confidence interval of
95.5 %) of CSSs calculated from uninjured intact rats
(control group).
Somatosensory assessment
Animals were anaesthetised with urethane (12.5 %w/v;
1.4 g/kg; i.p.) and maintained at 37 °C on a heating mat.
A tracheotomy was performed, and animals were placed
in a stereotaxic frame. The gracile nuclei were exposed
through the foramen magnum by head flection and re-
moval of overlying muscles and meninges. Both left and
right sciatic and sural nerves were exposed by the re-
moval of the overlying skin followed by a splitting inci-
sion of the gluteus maximum and semimembranosus
muscles, respectively. The exposed nerves were isolated
from adjacent connective tissues and bathed in paraffin
oil. Silver wire bipolar hook electrodes were used to stimu-
late sural nerves, and a single hook silver wire electrode
was used to record from sciatic nerves to ensure complete
recruitment of all sural nerve fibres upon electrical stimula-
tion (square wave pulse, 0.5–1.1 mA, 0.05 ms). A platinum
wire electrode was used to record from a single midline
position on the brainstem at a location that was established
to provide evoked potentials of equal magnitude and
latency from left and right sural nerve stimulation.
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Thirty-three individual evoked potentials were recorded
and averaged from the sciatic nerve and the brainstem in
response to repeated sural nerve stimulations. Signals re-
corded from the brainstem were then processed offline
(MATLAB, MathWorks). The averaged signal was band-
pass filtered (500–3350 Hz) and response magnitudes cal-
culated from the integral of rectified signals (integral limits:
5.00 ms before and 8.75 ms after the primary peak) after
subtraction from baseline levels obtained prior to the
stimulus. Latency was measured from the filtered signal
where it first exceeded 3 standard deviations (confidence
interval 99.7 %) of background levels.
Locomotor assessment
Prior to surgery, animals were trained to run along an
80-cm custom build transparent walking-track with mir-
rors that reflected left and right sides and underneath of
the animal. This enabled exquisite locomotor detail from
all sides of interest to be video captured simultaneously
from a single viewpoint. 2 h following surgery, initial re-
cordings of animals running three consecutive times
down the walking-track were acquired with a digital
camera (Sony, NEX-VG20EH) at 50 frames per second,
which provided adequate data for detailed gait analysis.
Recordings were repeated every 24 h post-surgery for 7
consecutive days. Each video file was coded and assessed
blind by one assessor. The BBB locomotor scale [40] for
the left and right hind-limbs was used to generate loco-
motor scores from video files assessed in slow motion.
Immunohistochemistry and TUNEL
Animals from both groups (SCI, n = 15; SCI+670, n = 15)
were divided into three recovery time points and sacri-
ficed at 1, 3 and 7 days post-injury. At the end of desig-
nated recovery periods, animals were transcardially
perfused with saline and 4 % buffered paraformaldehyde
(w/v). Harvested spinal cords were cryoprotected in
30 % sucrose (w/v), cryosectioned at 20 μm in the longi-
tudinal plane using a Leica CM1850 cryostat, and dorsal
sections labelled with primary antibodies (1:200) against
rat CD68 (ED-1 clone, MAB1435, Millipore), and
Arginase-1 (AB60176, Abcam) or CD80 (AB53003,
Abcam) to quantify microglia/macrophages (ED1+) and
polarized subtypes M1 (CD80+ED1+) and M2 (Arginase1
+ED1+), respectively. Tissue was subsequently incubated
with the appropriate secondary antibodies (1:1000,
Invitrogen, Alexa 594 conjugated chicken anti-goat
#A21468, Alexa 488 conjugated goat anti-mouse
#A31619, Alexa 594 conjugated goat anti-mouse
#A31623, Alexa 488 conjugated donkey anti-rabbit
#A21206). Slides were then incubated in Hoechst solu-
tion (2 μg/ml Sigma-Aldrich). Standard immunohisto-
chemical controls were included.
To detect cells undergoing apoptosis/necrosis, a TUNEL
assay was performed. Slides were incubated with 1:10
Terminal Deoxynucleotidyl Transferase (TdT) buffer
(125 mM Tris-HCl, 1 M sodium cacodylate, 1.25 mg/ml
BSA, pH 6.6) for 10 min and then 1-h incubation at 37 °C
with reaction mixture [0.5 enzyme unit/μl TdT (Roche
Applied Science) and 2.52 μM Biotin-16-dUTP (Roche
Applied Science) diluted in 1:10 TdT buffer]. This was
followed by 15 min incubation in 1:10 saline sodium
citrate (SSC) buffer (175.3 mg/ml sodium chloride,
88.2 mg/ml sodium citrate, pH 7.0) and blocked with 10 %
normal goat serum in 0.1 M PBS for 10 min before incu-
bating with secondary antibody in 0.1 M PBS (1:1000 dilu-
tion, Invitrogen, Alexa 488 conjugated streptavidin
S11223) at 37 °C for 30 min.
All image analysis was performed blind to the experi-
mental group. 2D images were constructed from three
colour channel (red, green and blue) images acquired
from a LED fluorescent microscope (Carl Zeiss Colibri)
with a ×20 objective and digital camera (AxioCam MRc 5)
with all settings kept constant for each channel. Cells with
co-labelling were quantified with ImageJ (v1.46r) using the
Cell Counter plugin that enables the placement of differ-
ent classes of markers onto an image. Cytoplasmic
markers, a class for each channel, were used to tag posi-
tive label in a single focal plane for all green and red chan-
nels that were examined independently. To define ED1+
cells, the accompanying DAPI+ nucleus (blue channel)
was tagged for cells where ED1 staining was clearly com-
plementing the DAPI surface profile. Double-labelled cells
(i.e., ED1+Arginase1+ or CD80+) were evaluated by scruti-
nising all tagged DAPI+ cells for co-labelling in red and
green channels. These cells were tagged again with an-
other marker class. All markers were automatically quan-
tified for each class by the software. Cells out of focus
were not included. Cell counts were obtained from dorsal
horn regions with viable tissue and quantified as the mean
of duplicate images, each covering a minimum area
0.05 mm2. The areas of interest were defined and quanti-
fied prior to cell quantification and included the dorsal
horn grey matter region as well as the white matter in the
surrounding dorsal columns and lateral funiculus. Cell
quantification is expressed as the number of cells per unit
area (mm2).
Statistics
All data expressed as boxplots with individual data
points in figures or as mean ± SEM in the main text, un-
less otherwise stated. Boxplots indicate the median
(thicker line), upper and lower quartiles with whiskers
extending to maximum and minimum values excluding
outliers (more than 1.5 times respective quartiles). Stat-
istical analysis was carried out using R or MATLAB, and
a criterion alpha level of 0.05 was adopted as statistically
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significant. Data sets were tested for normality and homo-
scedasticity, and t tests and linear mixed models (multi-
factor ANOVA) were applied for normally distributed data
(indicated by *) or Wilcoxon rank-sum (indicated by †)
where data was not normally distributed.
Results
Red light penetrates the spinal cord
We first set out to demonstrate that red light can pass
through superficial and deep structures underlying the
dorsal exterior surface and penetrate the entire spinal
cord (Fig. 1). The penetrating light could be seen with
the naked eye (example, Fig. 1a, b). The dorsal surface of
uninjured rats (n = 6) was exposed to the LED array and
670 nm light intensity measured at the light source sur-
face through the transparent treatment box which dir-
ectly contacts the rat dorsum during treatment (Fig. 1c,
intensity at dorsal surface; 35.4 ± 0.05 mW/cm2) and the
ventral surface of the spinal cord, where light had to
pass through an additional ~10 mm of the animals’ tis-
sues from dorsal surface (Fig. 1c, intensity at ventral sur-
face; 3.2 ± 0.6 mW/cm2). These data show that 91.1 ± 1.8 %
of the light from the LED array was absorbed/dispersed by
the tissues between the dorsal surface of the animal and the
ventral surface of the spinal cord (Fig. 1c, black arrow). To
indicate the approximate attenuation over the distance of
light travelling from the light source through to the
ventral spinal cord surface, we measured the intensity
at the approximate distance (10 mm) through the air
(33.0 ± 0.5 mW/cm2). This demonstrated that the ex-
pected attenuation (~7 %) of light is negligible over
the distance required to travel to the ventral surface
of the cord.
Surface temperature changes following light treatment
We measured the surface temperature of rats directly
before and 2 min after treatment. Twenty-seven readings
from sham-treated and 25 readings from light-treated
animals were acquired from four animals in each group
over consecutive days of treatment. While there was no
significant difference in the surface temperature of
sham-treated animals (before, 33.6 ± 0.23 °C; after, 33.6
± 0.25 °C), there was a small but significant increase
2 min after light treatment (before, 32.8 ± 0.36 °C; after,
33.5 ± 0.22 °C; p = 0.038, paired t test).
Red light reduces allodynia following spinal cord injury
To examine the effect of red light on the development
of neuropathic pain, we assessed sensitivity on six
regions over the rat dorsum using a T10 hemicontusion
spinal cord injury model that results in clear develop-
ment of hypersensitivity in most animals within 7 days.
The T10 spinal hemicontusion resulted in 63 % of
animals (n = 12) developing hypersensitivity in both
sham-treated (SCI, n = 19) and light-treated (SCI+670,
n = 19) groups at 7 days post-injury. The hypersensi-
tive subpopulation of rats from the SCI group had a
mean CSS (SCI, CSS: 25.3 ± 4.5) that was 3.7 × the
hypersensitive threshold (Fig. 2a). The mean CSS was
significantly reduced by 40 % (SCI+670, CSS: 14.5 ± 1.6;
2.1 × the hypersensitivity threshold) in the hypersensitive
subpopulation of rats from the SCI+670 group. Light
treatment significantly reduced At- (T9-T12 dermatomes)
and Below- (L2-L5 dermatomes) LSSs, which arose from
contralateral At-Level and both ipsi-and contralateral
Below-Level regions (Fig. 2b). Compared to the uninjured
control group (control, Fig. 2c), sham injury without light
treatment (shamSCI, n = 8) had no significant effect on
LSS or RSS despite two sham-injured animals developing
At-Level hypersensitivity. Light treatment of sham-injured
animals (shamSCI+670, n = 10) resulted in significant re-
ductions of At- and Below-LSS compared to the shamSCI
group (Fig. 2c). Thus, while the incidence of hypersensitiv-
ity was not altered by red light, the level of hypersensitivity
was markedly reduced At- and Below-levels in T10 con-
tused light-treated allodynic animals. Red light also caused
a significant reduction in sensitivity in 670-treated sham-
injured animals (shamSCI+670, CSS: 0.8 ± 0.5) compared
to uninjured control animals (control, CSS: 2.8 ± 0.8) as
well as normosensitive spinal cord injured animals (SCI,
CSS: 3.5 ± 0.9), even though these animals were not
hypersensitive.
Red light improves sensory conduction through dorsal
column pathways
Could red light cause an anaesthetic-like effect on soma-
tosensation that resulted in reduced sensitivity scores?
To rule out the possibility that red light causes a re-
duced responsiveness to innocuous stimuli by bringing
about a generalized inhibitory effect on somatic neural
pathway conduction, we quantified the functional integ-
rity of the sensory dorsal column pathway, at 7 days
post-injury. The dorsal column pathways were activated
by electrical stimulation of the left and right sural
nerves, and a recording electrode was placed on the
midline of the gracile nuclei (Fig. 3a). Stimulation of left
and right nerves from control animals (n = 7) evoke
responses of equal magnitude (Fig. 3b; right side: 101 ±
8 % of left side) and latency (Fig. 3c; left-right side
latency difference: 0.09 ± 0.03 ms) on both sides when
recorded from the same midline-positioned recording
electrode, while sham-treated T10 hemicontusion spinal
cord injury (n = 7) resulted in a 37 % reduction in
magnitude (right side: 63 ± 16 % of left side) and a 0.48
± 0.09 ms delay of the injured (right) pathway, when
comparing the intact (left) side. Red light treatment
(n = 7) rescued both the magnitude (Fig. 3b; right
side: 93 ± 17 % of left side) and latency (Fig. 3c;
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left-right side latency difference: −0.05 ± 0.35 ms) defi-
cits otherwise observed in the SCI group, indicating
that red light treatment restored sensory pathway
conduction, rather than impeding it. Furthermore, the
rescued magnitude and latency deficits in the SCI
+670 group indicates that their reduced sensitivity
scores (Fig. 2) were unlikely to have resulted from a
generalized reduction of somatic neural conduction.
We performed a variety of control experiments to valid-
ate our interpretations. There was no observable difference
of conduction magnitudes or latencies in any of the sham-
injured animals (shamSCI, n = 4; shamSCI+670, n = 4).
There was no significant difference between gracile nuclei
potentials evoked from the left sural nerve in any of the
groups (SCI, 15.9 ± 1.8 μV ·ms; SCI+670, 11.9 ± 2.4 μV ·ms;
control, 16.2 ± 3.6 μV ·ms; shamSCI, 10.8 ± 2.6 μV ·ms;
shamSCI+670, 15.0 ± 2.8 μV ·ms; p = 0.70, one-way
ANOVA). Similarly, there was no significant difference of
response latencies when evoked on the left side for all
groups (SCI, 33.7 ± 0.3 μV ·ms; SCI+670, 34.0 ± 0.4 μV ·ms;
control, 34.0 ± 0.4 μV ·ms; shamSCI, 34.2 ± 0.5 μV ·ms;
shamSCI+670, 34.7 ± 0.3 μV ·ms; p = 0.51, one-way
ANOVA). These control experiments indicated that dorsal
column pathway response magnitudes and latencies were
similar between the different groups and largely unaffected
contralateral to the injury.
Red light improves locomotor recovery
Could red light treatment cause motor deficits and
thereby result in reduced sensitivity scores? To rule out
the possibility that the red light impeded the animals’
ability to perform escaping locomotor behaviours, daily
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locomotor recovery was examined blind to the experi-
mental group (Fig. 4). We found that rather than
impeding locomotion, the SCI+670 group (n = 11) dem-
onstrated improved locomotor recovery as early as 2 days
post-injury on the ipsilateral side and 3 days post-injury
on the contralateral side compared to the sham-treated
group (n = 10). Although a group effect of red light im-
provement was evident on the ipsilateral side (p = 0.026,
linear mixed effects model with repeated measures), this
failed to reach significance on the contralateral side
(p = 0.055). There was a highly significant effect of
time for both sides (p < 2e-16). Locomotor improvements
observed in the SCI+670 group indicate that reduced sen-
sitivity scores in light-treated animals (Fig. 2) could not
have resulted from locomotor deficits.
Red light reduces cell death at the injury zone
To examine the effect of red light on cell death following
injury, the number of TUNEL+ cells was quantified at 1,
3 and 7 days post-injury in dorsal regions of the T10
spinal cord (Fig. 5, n = 5 for each time point). The SCI
group resulted in an increased density of TUNEL+ cells
in the dorsal spinal cord ipsilateral to the injury as early
as day 1 (contralateral 1.5 ± 1.5 cells/mm2; ipsilateral
96.8 ± 41.1 cells/mm2), reaching maximum levels by day
3 (contralateral 13.1 ± 5.6 cells/mm2; ipsilateral 126.8 ±
41.5 cells/mm2). The contralateral side had much fewer
cells where maximum levels were reached by day 7
(Fig. 5; contralateral 32.5 ± 32.5 cells/mm2; ipsilateral
74.2 ± 43.7 cells/mm2). Red light treatment resulted in a
significant group reduction of TUNEL+ cells in the ipsi-
lateral side, notably significant at the day 3 time point
when TUNEL+ cells were maximal in the sham-treated
group (1 dpi: 49.6 ± 25.2 cells/mm2; 3 dpi 18.2 ±
3.9 cells/mm2; 7 dpi 22.0 ± 6.1 cells/mm2). There was no
significant difference in TUNEL labelling on the contra-
lateral side between groups (1 dpi: 2 ± 2 cells/mm2; 3 dpi
6.2 ± 2.1 cells/mm2; 7 dpi 5.0 ± 3.9 cells/mm2).
Red light reduces total activated microglia/macrophages
but promotes the expression of the anti-inflammatory/
wound-healing (M2) subtype
Inflammation has long being implicated in the devel-
opment of neuropathic pain [27]. We therefore quan-
tified activated microglia/macrophages (ED1+ cells) at
1, 3 and 7 days post-injury in dorsal regions of T10
spinal cord (Fig. 6a–d, n = 5 for each time point). T10
spinal contusion resulted in an increase in ED1+ cell
density as early as day 1 post-injury, reaching max-
imum levels by day 3 in the ipsilateral side. Max-
imum levels were also reached at day 3 on the
contralateral side, but there were negligible ED1+ cells
at days 1 and 7. Light treatment significantly reduced
ED1 expression ipsilateral to the injury to approxi-
mately half that of the SCI group. Despite the low
levels of ED1+ cells in the contralateral side, red light
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treatment also resulted in a significant reduction of
ED1+ cells at the 3-day time point.
Microglia/macrophages can adopt pro- or anti-
inflammatory states [30]. To determine the effect of red
light treatment on the expression of pro-inflammatory
(M1) cells, cells co-expressing CD80 and ED1 were
quantified as a proportion of total ED1+ cells (Fig. 6e–h,
n = 5 for each time point). The proportion of CD80+ED1
+ cells ipsilateral to the injury was maximal at day 1 and
remained greater than 40 % of the ED1 population at
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days 3 and 7 in more than half of animals. CD80+ED1+
cells were only found at day 3 on the contralateral side
which coincided with the maximum number of ED1+
cells at that time point. Red light treatment did not have
a significant impact on the proportion of M1 cells on
either the ipsi- or contralateral sides. Note that no CD80
+ED1+ cells were encountered at days 1 and 7 contralat-
eral to the injury as ED1+ cells were also in small quan-
tities at these time points (Fig. 6a).
To determine the effect of red light treatment on the ex-
pression of anti-inflammatory/wound-healing (M2) micro-
glia/macrophages, ED1+ cells co-expressing Arginase-1
were quantified as a proportion of total ED1+ cells
(Fig. 6i–l, n = 5 for each time point). In the SCI group,
Arginase-1 expression increased with time ipsilateral to
the injury (p = 0.0048, one-way ANOVA) but peaked at
day 3 contralateral to the injury at the time when most
ED1+ cells were present in that region. Ipsilateral to the
injury, the SCI+670 group displayed significantly increased
proportions of Arginase1+ED1+ cells from day 1, reaching
approximately sevenfold that of the SCI group. This
greater Arginase1+ED1+ proportion in light-treated
animals was maintained at over one third of ED1+ cells for
the entire duration investigated for the majority of
animals. No Arginase1+ED1+ cells were detected contra-
lateral to the injury in the SCI+670 group; however, there
were very few ED1+ cells in this region (Fig. 6a). The
group effect failed to reach significance contralateral to the
injury (p = 0.0628) despite a significantly greater level of
Arginase1+ED1+ cells in the SCI group.
Discussion
We demonstrate that following spinal cord injury,
35 mW/cm2 of red (670 nm) light transcutaneously ap-
plied for 30 min/day for 7 days to the dorsal surface of
rats is sufficient to reach the entire spinal cord and re-
duce the expression of pain behaviours. These reduced
signs of allodynia are not due to sensorimotor deficits,
as red light treatment improves both sensory and motor
function. Alleviated hypersensitivity, improved tactile/
proprioception (dorsal column) pathway functional in-
tegrity and locomotor functional outcomes are preceded
by reduced numbers of dying cells and reduced numbers
of activated microglia/macrophages around the injury
zone. Furthermore, the proportion of anti-inflammatory/
wound-healing (M2) microglia/macrophages is greatly
enhanced by 24 h following light treatment.
We are confident that the power output of the red
light was sufficient to penetrate the entire rat spinal cord
as red light could be seen with the naked eye illuminat-
ing through to the ventral surface of the cord in the ca-
daver models. While penetration through to the rat
spinal cord was achievable with an intensity of 35 mW/
cm2, future studies would be required to determine the
exposure parameters to achieve an equivalent level of ir-
radiation in humans. Our finding of 91 % absorption
(9 % excess penetration) is a conservative measure for
two main reasons: (i) penetration measurements were
obtained through the hair of unshaven animal cadavers
(the injury site of all injured animals was shaven) and (ii)
deoxygenated haemoglobin absorbs 670 nm significantly
more than oxygenated haemoglobin [41, 42]. Measure-
ments from freshly scarified animals are therefore likely
to have increased levels of deoxygenated blood, and thus
reduced penetration, compared to live animals. Another
factor to consider is the small attenuation of light as a
function of distance from its source. Our estimation in-
dicates that over 93 % of the light would have reached
the spinal cord ventral surface if no intervening tissues
were present to absorb the light; thus, the effect of dis-
tance appears to be negligible. Nine percent excess
penetration (i.e. 91 % absorption) from the surface of the
skin (with hair intact) through all intervening tissue
layers to the ventral surface of the spinal cord with a
device delivering approximately 35 mW/cm2 is con-
sistent with a recent study that demonstrated an ex-
cess penetration of 6.6 % through the surface of the
skin and the muscle overlying the spinal cord with a
device producing approximately 16 mW/cm2 in Fisher
rat cadavers [9].
Temperature of sham-treated animals was not signifi-
cantly different before and after treatment, while light-
treated animals’ experienced a significant 1.2 °C increase.
This increase does not exceed the normal range for rat
tail skin temperature variations which have been re-
ported to oscillate by ± 2 °C within a 2-h time frame
[43]. However, as there was a small but significant
temperature increase 2 min after light treatment, it is
(See figure on previous page.)
Fig. 6 Anti-inflammatory microglia/macrophages are promoted early by red light treatment following T10 hemicontusion spinal cord injury. a–d
Total activated microglia/macrophages (ED1+) per mm2 contralateral (a) and ipsilateral (b) to the injury and example images from SCI (c) and SCI
+670 (d) groups. e–h M1 (pro-inflammatory) microglia/macrophages (CD80+ED1+ double labelled) expressed as a proportion of total ED1+ cells
contralateral (e) and ipsilateral (f) to the injury and example images from SCI (g) and SCI+670 (h) groups. i–l: M2 (anti-inflammatory) microglia/
macrophages (Arginase1+ED1+ double labelled) expressed as a proportion of total ED1+ cells contralateral (i) and ipsilateral (j) to the injury and
example images from SCI (k) and SCI+670 (l) groups. All example images are taken from the injury zone of the dorsal horn at 7 days post-injury.
Schematic cross section of spinal cord (bottom) indicates location of injury (dark grey penumbra) and region of quantification (light grey region).
Scale bars: 50 μm. *p < 0.05 (linear mixed model); **p < 0.01, ***p < 0.001 (Student’s t test); †p < 0.05, ††p < 0.01, †††p < 0.001 (Wilcoxon rank-sum)
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likely that there was a larger temperature increase dur-
ing the 30 min treatment period. We therefore cannot
rule out the possibility that temperature increases did
not impact on our findings. Nevertheless, red light treat-
ment does result in significant functional and cellular
improvements, regardless if temperature is a contribut-
ing factor. If temperature increases were to contribute
toward improved outcomes, it would be in contrast to
studies of hypothermic treatment which propose super-
ior outcomes following spinal cord injury [44–46]. As
the mechanisms of action for light-treatment improve-
ments remain to be elucidated, future investigations iso-
lating the effect of temperature and light are warranted.
To our knowledge, our study is the first to report a
red light-induced locomotor improvement following a
spinal cord injury, which contradicts the only other
study by Giacci et al. [9] that examined 670 nm on loco-
motor recovery with a daily dose of 28.4 J/cm2, an inten-
sity of 15.8 mW/cm2 for 30 min, i.e. less than half the
intensity of the present study. The compounded effect of
reduced intensity and a more severe contusion injury in
their study may explain this difference, and furthermore,
suggests that matching the appropriate light dosage to
the injury severity is of paramount importance.
Our T10 hemicontusion injury model resulted in allo-
dynia within 7 days in a subset of animals. We are
confident that our injury model results in neuropathic
pain because hypersensitivity developed above and below
the level, as well as contralateral to the injury, i.e. at der-
matomes that receive their innervation from outside the
injury epicentre. This observation is also consistent with
findings from an investigation using a C5 hemicontusion
injury model and which also found a subset of animals
developing allodynia from 7 days post-injury that lasted
for least 42 days [47]. Our observation of allodynia on
the animals’ dorsum is also consistent with a T13 hemi-
section injury model that also results in clear develop-
ment of hypersensitivity in most animals within 7 days
and that remains persists for several weeks [48].
We found that red light treatment reduced the sever-
ity, but not the incidence of hypersensitivity at 7 days
post-injury. As allodynia reached sensitivity levels of al-
most four times that of the hypersensitivity threshold,
we would expect that a milder injury causing sensitivity
scores closer to the hypersensitivity threshold boarder
would result in a reduction of both the severity and
incidence of hypersensitivity. The finding that the
shamSCI+670 group demonstrated sensitivity signifi-
cantly lower than that of the intact control and shamSCI
groups was curious. Sham injury may have activated
anti-nociceptive descending pathways such as periaque-
ductal grey/raphe magnus-mediated inhibition of dorsal
horn nociceptive inputs [49]. Thus, endogenous central
anti-nociceptive mechanisms, compounded by a red light-
induced anti-inflammatory microenvironment, could be
responsible for the sham-injured-light-treated animals ex-
pressing less sensitivity than observed in uninjured ani-
mals. This speculation warrants further investigation as
red light-augmented relief from pain would have signifi-
cant clinical relevance for post-surgical pain treatment.
Quantification of pain behaviours relies on sensory
and motor functional integrity. We are confident that
the reduced expression of allodynia in red light-treated
animals was not due to diminished general somatic
sensation or impeded motor function because red light
improved, rather than impeded these parameters. Loco-
motor recovery and sensitivity testing was scored blind
to the experimental group, and therefore, any subjective
bias was eliminated. Sural nerve evoked somatosensory
potentials in the gracile nuclei provided an objective and
precise measure of somatic sensory functional integrity
of both left and right dorsal column pathways. Sural
nerves were stimulated to recruit all nerve fibres, and
therefore, input to the spinal cord was identical on both
sides, while the recording conditions on the midline of
the gracile nuclei were also identical during the acquisi-
tion of evoked potentials elicited from pathways of both
sides. Therefore, the only difference in the responses be-
tween the left and right sides was due to alterations
within their respective dorsal column pathways. We fur-
ther confirmed this by demonstrating equal magnitudes
and latencies of somatosensory potentials in the gracile
nuclei when evoked from left and right sural nerves of
intact and sham-injured animals. Thus, our data indi-
cates that reduced expression of behavioural signs of
pain following red light treatment is unlikely to have re-
sulted from locomotor or sensory deficiencies, but
rather, represents a true reduction of pain experienced
by the light-treated rats.
While our study is the first to demonstrate red light-
induced pain relief from spinal cord injury, it is consist-
ent with peripheral nerve injury studies that report pain
relief accompanied by light-induced alterations to the
inflammatory response [13–15, 50, 51]. The functional
improvements found in red light-treated animals were
observed after a significant reduction in cell death was
apparent at day 3 post-injury, a time coincident with max-
imal levels of activated microglia/macrophages in the in-
jury zone of sham-treated animals. Our observations of
reduced ED1+ cells in 670-nm-treated animals is consist-
ent with that found in retinal damage [7], as well as an-
other study that demonstrated similar proportions of ED1
cell suppression lasting up to 14 days post-corticospinal
tract lesion in rats that received daily 810 nm diode laser
treatments [16]. In the latter study by Byrnes et al., they
also demonstrated functional improvements of some
motor tasks, also consistent with improved locomotor
function observed in our study. While we cannot
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speculate on the mechanisms for 810 vs. 670 nm wave-
lengths to suppress microglia/macrophage activation and
improve motor function, it is noteworthy that both wave-
lengths evoke peak levels of cytochrome C oxidase activity
and ATP production [52]. However, wavelength (i.e. 660
vs. 780 nm) has been shown to alter the expression of
inflammatory mediators expressed by activated pro-
inflammatory microglia/macrophages [37], and light dos-
age has been shown to alter the balance of M1/M2 cell
expression [53]. These in vitro studies suggest that other
mechanisms, unrelated to cytochrome C oxidase, may in-
fluence the inflammatory microenvironment following
light treatment. Furthermore, they highlight the necessity
for thorough investigations to establish the therapeutic
limits of any wavelength under investigation.
While others have demonstrated the impact of wave-
length and dose on inflammatory cells in vitro [37, 53],
to our knowledge, we are the first to demonstrate the ef-
fect of 670 nm light on the polarization of activated
microglia/macrophages following spinal cord injury in
vivo. The pattern and sequence of pro-inflammatory M1
(CD80+ED1+) cell activation, cell death, followed by
anti-inflammatory/wound-healing M2 (Arginase1+ED1+)
recruitment observed in sham-treated animals in our
study is consistent with what is expected under condi-
tions of spinal cord injury and repair [30, 31]. However,
our data indicates that red light-induced reduction of
cell death is preceded by the upregulation of M2 cells as
early as 1 day post-injury. This is intriguing because the
M2 cell expression preceded that of the M1 cells, indi-
cating that red light drastically altered the normal se-
quence of inflammatory events. We therefore speculate
that the early presence of protective M2 cells may have
caused the reduced subsequent population of dying
(TUNEL+) cells. Insufficient expression of the M2 sub-
type in spinal cord injury, in contrast to peripheral nerve
injury, has been suggested to be a contributing factor to
the poorer regenerative capacity and functional out-
comes in spinal cord injury compared to peripheral
nerve injury [30, 31]. The present study found that red
light had a strong impact on promoting the M2 cell
types as early as 24 h after treatment which was followed
by reduced levels of cell death and subsequent improve-
ment of sensory and motor functional outcomes there-
after. This is consistent with previous suggestions that
enhancing the M2 population during recovery from
spinal cord injury may indeed significantly contribute to
improving functional outcomes following spinal cord in-
jury [31].
Conclusions
Modulating the severity of neuropathic pain by simply
applying red light is an exciting prospect with great
significant clinical relevance, despite not yet fully
understanding the mechanism behind photobiomodula-
tion. Our data demonstrates that red light treatment, a
non-invasive and cost effective treatment, is able to sig-
nificantly reduce the severity of pain in rats acutely after
spinal cord injury, and these behavioural changes are
accompanied by alterations to the alternatively activated
macrophage population. Early pain intervention is con-
sidered important to avoid the prospects of developing
chronic pain [54]. As 670 nm light therapy is FDA ap-
proved, it could be quickly adopted as an adjunct to
early treatment of spinal cord injury. Not only could this
minimise the severity of pain to sufferers, it may also
provide collateral benefits which include functional im-
provements to other sensory/motor systems. However,
translation to human patients requires further studies to
determine exposure parameters such as the light inten-
sity necessary to penetrate the human spinal cord.
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